SCHEMBL30847809

SCHEMBL30847809

Cc1ccc2cnn(C)c2c1NS(=O)(=O)c1cnn(-c2cc(C(F)(F)F)ccn2)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ OXTR P30559 4/20 0.39
▸ AVPR1A P37288 2/20 0.36
▸ SLC40A1 Q9NP59 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ CYP2D6 P10635 2/20 0.33
▸ PSEN1 P49768 2/20 0.33
▸ PSEN2 P49810 2/20 0.33
▸ APH1B Q8WW43 2/20 0.33
▸ NCSTN Q92542 2/20 0.33
▸ APH1A Q96BI3 2/20 0.33
▸ PSENEN Q9NZ42 2/20 0.33
▸ KMT2A Q03164 2/20 0.33
▸ TSHR P16473 1/20 0.33
▸ SCN9A Q15858 4/20 0.33
▸ CYP3A4 P08684 1/20 0.33
▸ MCL1 Q07820 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27132785 1.00 OXTR (0.39) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL27133357 0.91 OXTR (0.37) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL30847918 0.91 OXTR (0.37) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL30848101 0.90 SCN9A (0.39) SLC40A1CYP2D6PSEN1PSEN2APH1B
SCHEMBL27132349 0.90 SCN9A (0.39) SLC40A1CYP2D6PSEN1PSEN2APH1B
SCHEMBL27132955 0.90 MCL1 (0.38) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL27142081 0.90 KDM4E (0.37) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL30847762 0.90 KDM4E (0.37) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL30848059 0.90 MCL1 (0.38) OXTRAVPR1ASLC40A1KDM4EALDH1A1
SCHEMBL27143367 0.90 OXTR (0.35) OXTRAVPR1ASLC40A1SCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577536-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY Hotspot Therapeutics, Inc. (US) 2025-07-02 — — EP disclosed
WO-2024044730-A1 PYRAZOLYLSULFONAMIDE COMPOUNDS AND THEIR USE IN THERAPY HOTSPOT THERAPEUTICS, INC. (US) 2024-02-29 — — WO disclosed
Send feedback